Abisamis, Tito J.
HRN: 09-17-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/26/2023
12/03/2023
IV
500mg
Q8H
Aspiration Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes